NSPR Insider Trading Activity and SEC Form 4 Filings
NSPR insider trading summary
Over the past 12 months, insiders at InspireMD, Inc. (NSPR) reported 18 open-market purchases worth $518K by 4 insiders and 2 sales worth $28K by 1 insider on SEC Form 4. Net insider buying was $490K.
Latest NSPR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 27, 2026 | Paul Stuka | Director | Buy | $18K (20,000 @ $0.88) |
| May 19, 2026 | Shane Thomas Gleason | Chief Commercial Officer | Sell | $23K (22,778 @ $1.01) |
| May 14, 2026 | Paul Stuka | Director | Buy | $6K (5,000 @ $1.15) |
| May 13, 2026 | Paul Stuka | Director | Buy | $12K (10,000 @ $1.16) |
| May 12, 2026 | Marvin Slosman | CEO and President | Buy | $25K (21,000 @ $1.20) |
| May 11, 2026 | Paul Stuka | Director | Buy | $12K (10,000 @ $1.19) |
| May 11, 2026 | Paul Stuka | Director | Buy | $12K (10,000 @ $1.19) |
| May 8, 2026 | Paul Stuka | Director | Buy | $76K (65,626 @ $1.16) |
| May 8, 2026 | Paul Stuka | Director | Buy | $76K (65,626 @ $1.16) |
| May 7, 2026 | Paul Stuka | Director | Buy | $7K (6,378 @ $1.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.